Literature DB >> 15175008

Overexpression of inactive arylsulphatase mutants and in vitro activation by light-dependent oxidation with vanadate.

Terri M Christianson1, Chris M Starr, Todd C Zankel.   

Abstract

Arylsulphatases B (ASB) and A (ASA) are subject to a unique post-translational modification that is required for their function. The modification reaction, conversion of an active-site cysteine into a formylglycine, becomes saturated when these enzymes are overexpressed. We have removed the possibility of in vivo modification by expressing mutants of ASB and ASA in which the active-site cysteine is substituted with a serine. These mutants are expressed much more efficiently when compared with the native enzymes under identical conditions. The purified ASB mutant can then be converted into catalytically active ASB in vitro using vanadate and light.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175008      PMCID: PMC1133815          DOI: 10.1042/BJ20040447

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Paraffin-embedded tissue as a source of RNA for gene expression analysis in oral malignancy.

Authors:  M T Cairns; S Church; P G Johnston; K V Phenix; J J Marley
Journal:  Oral Dis       Date:  1997-09       Impact factor: 3.511

2.  Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases.

Authors:  T Dierks; M R Lecca; P Schlotterhose; B Schmidt; K von Figura
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  Recombinant human sulphamidase: expression, amplification, purification and characterization.

Authors:  J Bielicki; J J Hopwood; E L Melville; D S Anson
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

4.  Sulfatases, trapping of the sulfated enzyme intermediate by substituting the active site formylglycine.

Authors:  M Recksiek; T Selmer; T Dierks; B Schmidt; K von Figura
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

5.  Arg538 to Cys mutation in a CpG dinucleotide of the human biotinidase gene is the second most common cause of profound biotinidase deficiency in symptomatic children.

Authors:  R J Pomponio; K J Norrgard; J Hymes; T R Reynolds; G A Buck; R Baumgartner; T Suormala; B Wolf
Journal:  Hum Genet       Date:  1997-04       Impact factor: 4.132

6.  Conversion of cysteine to formylglycine in eukaryotic sulfatases occurs by a common mechanism in the endoplasmic reticulum.

Authors:  T Dierks; M R Lecca; B Schmidt; K von Figura
Journal:  FEBS Lett       Date:  1998-02-13       Impact factor: 4.124

7.  Characterization of iduronate sulphatase mutants affecting N-glycosylation sites and the cysteine-84 residue.

Authors:  G Millat; R Froissart; I Maire; D Bozon
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

8.  Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis.

Authors:  G Lukatela; N Krauss; K Theis; T Selmer; V Gieselmann; K von Figura; W Saenger
Journal:  Biochemistry       Date:  1998-03-17       Impact factor: 3.162

9.  Chemistry and mechanism of vanadate-promoted photooxidative cleavage of myosin.

Authors:  J C Grammer; J A Loo; C G Edmonds; C R Cremo; R G Yount
Journal:  Biochemistry       Date:  1996-12-03       Impact factor: 3.162

Review 10.  A novel protein modification generating an aldehyde group in sulfatases: its role in catalysis and disease.

Authors:  K von Figura; B Schmidt; T Selmer; T Dierks
Journal:  Bioessays       Date:  1998-06       Impact factor: 4.345

View more
  1 in total

1.  Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects.

Authors:  S Bhattacharyya; L Feferman; J K Tobacman
Journal:  Oncogene       Date:  2013-11-18       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.